Your ANSwer for Workers' Compensation Medical Cost Containment

Call Us Today!|info@ans-solutions.com
  • workers compensation industry technology
    Permalink Gallery

    How Technology Is Shaping The Workers’ Compensation Industry

How Technology Is Shaping The Workers’ Compensation Industry

The technology now used within today’s workers’ comp industry is remarkable compared to what was available just a few decades prior. A dominant component of advocacy, claims, and treatment, technology is helping employers and insurers work the bugs out of the process, producing amazing results and the promise of even more unbelievable advancements on the horizon…

How is Technology Reshaping the Workers’ Compensation Industry?

  • Paper Falls by the Wayside
    • NOW: Endless forms and lost paperwork are no longer, replaced by automated forms, electronic signatures and correspondence that is both faster and easily […]
April 10th, 2017|Drug Utilization Review, Medical Cost Projection, Pharmacotherapy Review|Comments Off on How Technology Is Shaping The Workers’ Compensation Industry

The ER and Opioids

A common thread has been found in opioid addiction, winding its way from the ER and into homes across the nation. Beginning as a single prescription for a minor issue or unexpected injury, ER physicians are inadvertently rolling the dice and chancing long-term addiction in their quest to simply relieve pain, when there could be better alternatives.

How Commonly are Opioids Tossed-Out in the ER?

Medical researchers studied hundreds of thousands of Medicare-paid ER admissions nationwide, and uncovered a surprising trend in standard approaches to treating […]

March 27th, 2017|Pharmacotherapy Review|Comments Off on The ER and Opioids

The Position of Workers’ Compensation in 2017

With the election of a new president who is ushering in a new era for the government, the trickle-down effect to the workers’ compensation industry just might sweep you off your feet. Prepare yourself with the industry knowledge you need, and avoid being overtaken by the tsunami…

The 2017 Workers’ Compensation Industry Issues to Watch:

  • The Affordable Care Act (ACA)
    Like a rogue wave, changes to the ACA may pop-up with little notice. These changes will influence the industry, including claims frequency, claims shifting, and cost shifting if/when private insurance is lost […]

March 13th, 2017|Workers Compensation Industry, Workers Compensation Payers|Comments Off on The Position of Workers’ Compensation in 2017

Naloxone (Narcan): What Workers’ Comp Payers Need to Know

Though it has been on the market since 1971, this year is expected to be a landmark year in naloxone (Narcan) sales nationwide, and this trend is expected to continue due not only to the opioid epidemic sweeping the nation, but the fact that opioids still remain the most frequently prescribed category of medication used in workers’ comp pain management.

Preventing Death from Opioid Overdose

In its hallmark form, naloxone was approved for injection by the FDA in 1971. An opioid agonist, it was used in hospital and emergency settings […]

February 27th, 2017|Workers Compensation Industry, Workers Compensation Payers|Comments Off on Naloxone (Narcan): What Workers’ Comp Payers Need to Know
  • healthcare plans opioids ANS Solutions pharmacotherapy review
    Permalink Gallery

    Landmark Reforms Hoped to Aid New York in the Fight against Opioid Addiction

Landmark Reforms Hoped to Aid New York in the Fight against Opioid Addiction

It is hoped to be a happier new year for Empire State residents suffering from opioid abuse. In a landmark legislative package that took effect January 1st of this year, health insurance plans will now be required to cover treatment services to New Yorkers suffering opioid addiction. In a state plagued by the effects of opioids and heroin, whose overdose death rates are far outpacing nearly every state in the union, legislators are hopeful those grappling with the effects of these drugs can finally gain access to the help […]

February 13th, 2017|Pharmacotherapy Review|Comments Off on Landmark Reforms Hoped to Aid New York in the Fight against Opioid Addiction

Comorbidities Compound Workers’ Comp Costs & Recovery

Underlying Conditions Complicate Workers’ Comp Injury Rehabilitation

New research from a Harbor Health Systems study demonstrates the significant impact of underlying conditions on workers’ comp claims. Commonly associated with higher costs and increased duration, this latest research illustrates an undeniable link between patients with comorbidities and undesirable claims outcomes.

A Problematic Pile-Up

Analyzing data from more than 7,000 workers’ comp claims, encompassing seven common comorbidities: Obesity, hypertension, diabetes, mental health, addiction, tobacco use, and combination comorbidities, claims associated with comorbid conditions were found to have incurred an array of undesirable side […]

January 30th, 2017|Pharmaceutical Cost Containment, Pharmacotherapy Review, Workers Compensation Industry|Comments Off on Comorbidities Compound Workers’ Comp Costs & Recovery

New Opioids Reduce Pain – and Addiction Risk

A new generation of opioid drugs are on the horizon, possibly offering the much maligned class of drugs a second chance to make a good impression. After years of opioids like oxycodone and fentanyl driving up drug addiction rates nationwide, a second subset of once odious opioids is being introduced, touting all the painkilling power of its conventional counterpart – less the dangerous and deadly side effects.

A Different Approach

While pharmaceutical companies continue to crank out new prescription formulations geared toward treating the side effects of opioid drug use […]

January 17th, 2017|Drug Utilization Review, Opioid Abuse, Pharmacotherapy Review|Comments Off on New Opioids Reduce Pain – and Addiction Risk
  • prescription drugs ANS pharmacotherapy review
    Permalink Gallery

    Alabama Doctor Arrested In Connection with Matt Roberts of 3 Doors Down Overdose Death

Alabama Doctor Arrested In Connection with Matt Roberts of 3 Doors Down Overdose Death

In mid-August of this year, fans were stunned by the death of 38-year-old Matt Roberts, former guitarist of 3 Doors Down. Alabama physician Dr. Richard Snellgrove was arrested November 16th for allegedly providing the rocker with drugs outside the course of his professional practice. Snellgrove prescribed some five different medications, including methadone, hydrocodone, lorazepam and fentanyl — all prescribed in the names of different individuals, but intended for Roberts.

Slated to perform at a charity event for veterans, the rocker’s father, Darrell Roberts, who often traveled […]

December 22nd, 2016|Opioid Abuse, Pharmaceutical Industry, Pharmacotherapy Review|Comments Off on Alabama Doctor Arrested In Connection with Matt Roberts of 3 Doors Down Overdose Death

The Impact of Workers’ Compensation Compounding

As custom-made compound prescriptions concoctions continue to rack-up higher workers’ compensation costs, insurers are scrambling to find alternatives and employers are looking for relief from equally inflated premiums. With little to no evidence as to the efficacy of such creations, many states have implemented treatment guidelines directing doctors to more evidentiary-based, easily reimbursable options. Despite guidelines and formularies however, loopholes in coverage continue to allow providers to sell millions of dollars of compounds, with many companies submitting inflated reimbursement bills in their attempts to get paid.

A Growing Issue in […]

December 15th, 2016|Drug Utilization Review, Workers Compensation Industry|Comments Off on The Impact of Workers’ Compensation Compounding
  • Permalink Gallery

    New FDA Warning: Avoid Prescribing Opioids & Benzos Together

New FDA Warning: Avoid Prescribing Opioids & Benzos Together

In a recent announcement by the FDA, boxed warning labels will now be required to advise against the utilization of prescription opioid pain medicines alongside benzodiazepines unless no other adequate alternative treatment method exists. Warnings about the risks of combining these two classes of drugs are nothing new. Already required on drug warning labels, additional black box warnings are an effort by the FDA to reach out to those who may have “missed the message.”

Classified as Central Nervous System (CNS) depressants, each drug alone can trigger side effects such […]

November 21st, 2016|Pharmaceutical Industry, Pharmacotherapy Review|Comments Off on New FDA Warning: Avoid Prescribing Opioids & Benzos Together